Calidi Biotherapeutics In...
(CLDI)
undefined
undefined%
At close: undefined
1.23
1.65%
After-hours Jan 03, 2025, 05:28 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Revenue | n/a | 45.00K | 449.00K | n/a |
| Cost of Revenue | 1.26M | 274.00K | 94.00K | n/a |
| Gross Profit | -1.26M | -229.00K | 355.00K | n/a |
| Operating Income | -28.99M | -23.13M | -1.78M | -6.77M |
| Interest Income | n/a | n/a | n/a | n/a |
| Pretax Income | -29.20M | -25.42M | 3.39M | -7.93M |
| Net Income | -29.22M | -25.43M | 3.39M | -7.94M |
| Selling & General & Admin | 15.98M | 15.64M | 1.78M | 3.59M |
| Research & Development | 13.01M | 7.26M | 4.67M | 3.18M |
| Other Expenses | n/a | -5.00K | 9.00K | 4.00K |
| Operating Expenses | 28.99M | 22.90M | 1.78M | 6.77M |
| Interest Expense | 1.07M | 158.00K | 614.00K | 163.00K |
| Selling & Marketing Expenses | n/a | -260.00K | -4.38M | n/a |
| Cost & Expenses | 28.99M | 23.17M | 1.78M | 6.77M |
| Income Tax | 16.00K | 11.00K | 11.00K | 4.00K |
| Shares Outstanding (Basic) | 16.89M | 850.50K | 2.88M | 35.91M |
| Shares Outstanding (Diluted) | 1.69M | 850.50K | 2.88M | 35.91M |
| EPS (Basic) | -1.73 | -29.9 | 1.18 | -0.22 |
| EPS (Diluted) | -17.3 | -29.9 | 1.18 | -0.22 |
| EBITDA | -27.58M | -25.00M | -9.45M | -6.65M |
| Depreciation & Amortization | 1.26M | 260.00K | 153.00K | 117.00K |